<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0001096637
<NAME> GENE-CELL, INC.

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                         148,605
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               149,836
<PP&E>                                         263,910
<DEPRECIATION>                                 123,227
<TOTAL-ASSETS>                                 315,337
<CURRENT-LIABILITIES>                           43,956
<BONDS>                                         28,738
                                0
                                          0
<COMMON>                                        17,778
<OTHER-SE>                                     224,865
<TOTAL-LIABILITY-AND-EQUITY>                   315,337
<SALES>                                              0
<TOTAL-REVENUES>                                 6,221
<CGS>                                                0
<TOTAL-COSTS>                                  341,733
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               4,978
<INCOME-PRETAX>                              (342,976)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (342,976)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (342,976)
<EPS-BASIC>                                     (0.02)
<EPS-DILUTED>                                   (0.02)


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission